
ETC-1002(ESP-55016) is a novel, first-in-class, orally available, once-daily LDL-C lowering малая молекула; activator of hepatic AMP-activated protein киназы (AMPK); also has мощный inhibitory activity against hepatic ATP-citrate lyase(IC50=29 uM).
ETC-1002(ESP-55016) is a novel, first-in-class, orally available, once-daily LDL-C lowering small molecule; activator of hepatic AMP-activated protein kinase (AMPK); also has potent inhibitory activity against hepatic ATP-citrate lyase(IC50=29 uM).
Вращайте мышью · Колесо — масштаб
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.